Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug
November 24, 2014 at 16:36 PM EST
Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors...